Posted on by

Drug firm fined for huge price rise that hit NHS



Share

This specialisation, the Advanz website boasts, “provides essential cost-savings to the NHS and wider European healthcare”. The Competition and Markets Authority’s investigation found another motivation, at least when it came to the supply of one type of thyroid tablets, which contain the chemical liothyronine, to the NHS.

Read More

Related posts:

French holiday bookings surge after rule change
Ovo Energy tells staff it will cut a quarter of its workforce
Next cuts sick pay for unvaccinated staff forced to self-isolate
Omicron takes out 3% of the workforce and a fifth of firms see rise in cancellations


Amplifying Patient Voices: White Swan’s AI-Driven Approach to Transforming Healthcare

April 28, 2024
Read More...

Revolutionizing Chemotherapy: Carole Spangler Vaughn’s Breakthrough in Combatting Peripheral Neuropathy

April 28, 2024
Read More...

The Future of AI in Marketing: Insights from Erik Huberman at the 2024 Global AI Conference

April 16, 2024
Read More...

Revolutionizing Hospitality: How Predictive Personalization Boosts Revenue

April 16, 2024
Read More...

Integrating AI in Humanoids and Deep Tech: A Strategic Insight with Shaloo Garg at the 2024 Global AI Conference

April 16, 2024
Read More...

How Generative AI is Revolutionizing the Retail Industry: Insights from Microsoft’s ShiSh Shridhar

April 14, 2024
Read More...

From Inspiration to Impact: Julie Davitz’s Vision for Transformative Media Engagement

March 31, 2024
Read More...

Empowering Small Businesses: Jeffery Boyle’s Vision of Accessible AI with Bemodo

March 31, 2024
Read More...

Josh Mangum at 1MediaWorld: Mastering the Human-AI Nexus for Business Success

March 31, 2024
Read More...

Navigating the Nexus of Filmmaking and Financial Reform: The Tobias Deml Blueprint

March 28, 2024
Read More...